Thank you. On the long-term possibilities, the second one is health care wait lists and wait times, and there's obviously a certain amount of interest in that. It seems to me we've accommodated a bit of a preview of it by having one meeting on it to see just how much meat there is—whether it would be the basis of, say, a four-month study in the fall, or something like that. It would at least let us get our feet wet on that subject.
In the same way, the third suggestion for long-term studies is prescription drugs. Back in the short-term studies, there are two or three things that fit in under there. So I'm wondering, if we have time, Mr. Chairman, before the House rises, whether we might have one meeting on that to get some little updates to see whether this is something we might want to study in the fall.